PEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A

References

• Harni R, Ezhumalai M, Kodukkur VP. Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur J Pharmacol 2012;676:89–94
   PubMed Web of Science ®Google Scholar
• Puli S, Lai JCK, Bhushan A. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J Neuro-Oncol 2006;79:135–42
   PubMed Web of Science ®Google Scholar
• Kole L, Giri B, Manna SK, et al. Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation. Eur J Pharmacol 2011;653:8–15
   PubMed Web of Science ®Google Scholar
• Silva CM, Shupnik MA. Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. Mol Endocrinol 2007;21:1499–512
   PubMed Web of Science ®Google Scholar
• Leung YK, Lee MT, Lam HM, et al. Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids 2012;77:727–37
   PubMed Web of Science ®Google Scholar
• Moon YJ, Shin BS, An G, Morris ME. Biochanin A inhibits breast cancer tumor growth in A murine xenograft model. Pharm Res – Dordr 2008;25:2158–63
   PubMed Web of Science ®Google Scholar
• Ying C, Hsu JT, Shieh SC. Growth inhibition of human endothelial cells by the phyto-oestrogen biochanin A, a metabolite of genistein. Brit J Nutr 2001;85:615–20
   PubMed Web of Science ®Google Scholar
• Tao C, Cheng H, Zhou K, et al. Preparation and char acterization of Biochanin A loaded solid lipid nanoparticles. Asian J Pharm 2012;6:275–81
   Google Scholar
• Zhang X, Pan W, Gan L, et al. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem Pharm Bull 2008;56:1645–50
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 2011;415:232–43
   PubMed Web of Science ®Google Scholar
• Liu D, Zhang N. Cancer chemotherapy with lipid-based nanocarriers. Crit Rev Ther Drug 2010;27:371–417
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT. Optimization of nanostructured lipid carriers for lutein delivery. Colloid. Surf A 2010;353:149–56
   Web of Science ®Google Scholar
• Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 2011;6:715–28
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylenem glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 2010;49:6288–308
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, et al. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 2011;32:6291–301
   PubMed Web of Science ®Google Scholar
• Yoshizawa Y, Kono Y, Ogawara KI, et al. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy. Int J Pharm 2011;412:132–41
   PubMed Web of Science ®Google Scholar
• Kanaras AG, Kamounah FS, Schaumburg K, et al. Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters. Chem Commun 2002;20:2294–5
   PubMed Web of Science ®Google Scholar
• Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug 2003;20:357–403
   PubMed Web of Science ®Google Scholar
• Hu L, Xing Q, Meng J, Shang C. Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles. AAPS PharmSciTech 2010;11:582–7
   PubMed Web of Science ®Google Scholar
• Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62–76
   Google Scholar
• Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 2010;394:179–85
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping Q, et al. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009;137:217–23
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Zhang D, et al. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 2012;50:523–9
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Drug Deliv Rev 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Li XW, Lin XH, Zheng LQ, et al. Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearate-modified solid lipid nanoparticles. Colloid Surf A 2008;317:352–9
   Web of Science ®Google Scholar
• Kuo YC, Shih KH, Yang JT. Capillary electrophoresis of bone marrow stromal cells with uptake of heparinfunctionalized poly(lactide-co-glycolide) nanoparticles during differentiate-on towards neurons. Electrophoresis 2010;31:315–23
   PubMed Web of Science ®Google Scholar
• Makino K, Yamamoto N, Higuchi K, et al. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids Surf B 2003;27:33–9
   Web of Science ®Google Scholar
• Han F, Li S, Yin R, et al. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf A: Physicochem Eng Aspects 2008;315:210–16
   Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 2009;71:349–58
   PubMed Web of Science ®Google Scholar
• Huang X, Chen YJ, Peng DY, et al. Solid lipid nanoparticles as delivery systems for Gambogenic acid. Colloids Surf B 2013;102:391–7
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MH. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996;129:159–73
   Web of Science ®Google Scholar
• Tsai M-J, Wu P-C, Huang Y-B, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 2012;423:461–70
   Google Scholar
• Zheng D, Dai W, Zhang D, et al. In vivo studies on the oridonin-loaded nanostructured lipid carriers. Drug Deliv 2012;19:286–91
   PubMed Web of Science ®Google Scholar
• Wan F, You J, Sun Y, et al. Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro. Int J Pharm 2008;359:104–10
   PubMed Web of Science ®Google Scholar
• You J, Wan F, Cui FD, et al. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int J Pharm 2007;343:270–6
   PubMed Web of Science ®Google Scholar
• Olbrich C, Kayser Q, Müller RH. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int J Pharm 2002;237:119–28
   PubMed Web of Science ®Google Scholar
• Jia XB, Chen J, Lin HM, Hu M. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther 2004;310:1103–13
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Zhang Y, et al. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci 2011;43:174–9
   Google Scholar
• Lindmark T, Nikkila T, Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. Pharmacol J Exp Ther 1995;275:958–64
   PubMed Web of Science ®Google Scholar
• Tanigawara Y, Yamaoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci 1982;71:1129–33
   Google Scholar
• Liu DH, Liu ZH, Wang LL, et al. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B 2011;85:262–9
   PubMed Web of Science ®Google Scholar
• Dye JA, McKiernan BC, Jones SD, et al. Sustained-release theophylline pharmacokinetics in the cat. J Vet Pharmacol Therap 1989;12:133–40
   Google Scholar
• Wong HL, Rauth AM, Bendayan R, et al. A new polymerylipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res 2006;23:1574–85
   PubMed Web of Science ®Google Scholar